Form 4: BridgeBio Pharma CFO Brian Stephenson Reports Stock Transactions
SEC Form 4 Filing
Brian Stephenson, CFO of BridgeBio Pharma, reports exercising stock options and selling shares under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On February 25, 2025, Brian C. Stephenson, CFO and Treasurer of BridgeBio Pharma, executed transactions involving the company's common stock.
- Stephenson exercised options to acquire 8,500 shares at a price of $17.
- He then sold 8,400 shares at a weighted average price of $33.1782, with prices ranging from $32.63 to $33.53 per share.
- An additional 100 shares were sold at $34.18 per share.
- These transactions were conducted under a Rule 10b5-1 sales plan adopted on March 22, 2024.
- Following these transactions, Stephenson directly owns 102,464 shares of common stock and holds options for 440,170 shares.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by a company executive. It doesn't inherently indicate positive or negative sentiment, as the transactions are conducted under a pre-arranged plan.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The use of a 10b5-1 plan suggests a pre-arranged strategy to avoid accusations of insider trading.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan suggests the transactions were planned and not based on inside information.
Key Dates
| Date | Description |
|---|---|
| 2019-06-26 | Start date for the vesting of the stock options in 48 equal monthly installments. |
| 2023-06-26 | End date for the vesting of the stock options in 48 equal monthly installments. |
| 2024-03-22 | Date the Reporting Person adopted the Rule 10b5-1 sales plan. |
| 2025-02-25 | Date of the reported transactions (exercise of options and sale of shares). |
| 2025-02-27 | Date of the report. |
| 2029-06-26 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.